The forecasted data for cervical cancer screening in France from 2024 to 2028 indicates a marginal but steady decline in the percentage of women aged 20-69 screened, from 58.6% in 2024 to 58.4% in 2028. This slight decrease suggests a nearly stable participation rate in cervical cancer screening programs over the five-year period, with a year-on-year variation showing a negligible decrease. Given the stability, the compound annual growth rate (CAGR) over this period is expected to be minimal, reflecting a consistent screening uptake among the target population.
Looking ahead, it’s crucial to monitor factors that could influence these trends, including advancements in screening technologies, changes in public health policies, and awareness campaigns aimed at increasing screening participation. Additionally, the impact of the COVID-19 pandemic on healthcare access and preventive care services could also play a significant role in future screening rates.
